Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
rail service There are many additional perks & programs with the CU Advantage . Qualifications: Minimum Qualifications: Entry Level Bachelor’s degree in biology, molecular biology, chemistry, genetics
-
osteoarthritis, musculoskeletal biology, and gut microbiome with a track record of publications supporting experience in these areas. Key Responsibilities: Analysis and dissemination of results related to ongoing
-
molecular biology techniques. The successful candidate will perform molecular and cellular biology experiments such as immunohistochemical staining, western blotting, molecular cloning, cell culture, qPCR
-
rail service There are many additional perks & programs with the CU Advantage . Qualifications: Minimum Qualifications: Bachelor’s degree in biology, molecular biology, chemistry, genetics or related
-
in biology, molecular biology, chemistry, genetics, or related field Substitution: A combination of education (such as the completion of a Certified Veterinary Technician associate’s program with a
-
the Quansys-2 for the analysis of micronutrients and other biological analytes as biomarkers for human nutrition studies. University of Colorado Anschutz Medical Campus is committed to recruiting and
-
research across a wide biological scale for fundamental scientific understanding with applications to many disease contexts. The overarching goal is to reach a level of molecular insight that helps develop
-
Biology, Data Science, or related field Experience training and/or analyzing neural network models with Pytorch One or more (1+) year professional level research experience One or more (1+) year of
-
bachelor’s degree in Clinical Laboratory Science, Molecular Biology, Biochemistry, Pathology, or a directly related field from an accredited institution. Intermediate Level: A bachelor’s degree in Clinical
-
T-cell exhaustion and sequestration. This strong immunologic foundation serves as the basis for our active development of cell and biologic therapeutics, including chimeric antigen receptor (CAR) T